Certified by Founder Lodge
MS&AD Ventures
United States - Menlo Park, California
INVESTOR
1 Disclosed Funding Rounds $42,000,000
19 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
MS&AD Ventures is an early stage venture fund looking broadly at technology companies in Fintech, InsurTech, AI, IOT, Big Data and Cybersecurity.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 02 ,2022 | Series B | $42,000,000.00 |
| Company | Date | Round | Raised |
|---|---|---|---|
BeeHero |
December, 02 ,2022 | Series B | $42,000,000 |
Coverflex |
February, 02 ,2023 | Series A | $15,000,000 |
Pliant |
February, 22 ,2023 | Series A | $28,000,000 |
FutureProof Technologies |
May, 05 ,2022 | Unknown | $6,500,000 |
Assured Allies |
March, 08 ,2023 | Series B | $42,500,000 |
Future Family |
April, 05 ,2022 | Series B | $25,000,000 |
Socotra |
March, 15 ,2022 | Series C | $50,000,000 |
Redkik |
February, 09 ,2022 | Seed | $3,300,000 |
Intellect (YC S21) |
January, 25 ,2022 | Series A | $10,000,000 |
Accelerant |
January, 12 ,2022 | Exit | $190,000,000 |
Marble |
May, 09 ,2023 | Seed | $4,200,000 |
Terminal Industries |
July, 21 ,2023 | Seed | $17,000,000 |
Tradeteq |
September, 11 ,2023 | Series A | $12,500,000 |
Flex (US) |
September, 20 ,2023 | Series A | $120,000,000 |
Mulberri, Inc. |
December, 08 ,2023 | Series A | $6,750,000 |
Artificial Labs |
February, 13 ,2024 | Series A | $10,111,520 |
Armilla AI |
February, 20 ,2024 | Seed | $4,500,000 |
Agio Ratings |
March, 06 ,2024 | Pre-Seed | $4,600,000 |
Sidekick |
June, 14 ,2024 | Seed | $8,500,000 |
BeeHero
Coverflex
Pliant
FutureProof Technologies
Assured Allies
Future Family
Socotra
Redkik
Intellect (YC S21)
Accelerant
Marble
Terminal Industries
Tradeteq
Flex (US)
Mulberri, Inc.
Artificial Labs
Armilla AI
Agio Ratings
Sidekick
dezerv.
FalconX
Kristal.AI
Finary
Savart
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)